NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 66 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $401,677 | +1.7% | 483,948 | -14.3% | 0.00% | – |
Q1 2023 | $395,133 | +26.4% | 564,475 | -8.1% | 0.00% | – |
Q4 2022 | $312,497 | -45.1% | 613,942 | -31.0% | 0.00% | – |
Q3 2022 | $569,000 | -39.3% | 889,298 | -2.4% | 0.00% | – |
Q2 2022 | $938,000 | -80.5% | 910,832 | -64.4% | 0.00% | – |
Q1 2022 | $4,810,000 | -61.7% | 2,558,479 | -1.8% | 0.00% | – |
Q4 2021 | $12,555,000 | -34.9% | 2,604,645 | -2.4% | 0.00% | -100.0% |
Q3 2021 | $19,299,000 | -20.8% | 2,669,276 | +1.2% | 0.00% | 0.0% |
Q2 2021 | $24,358,000 | -27.0% | 2,638,758 | -2.6% | 0.00% | 0.0% |
Q1 2021 | $33,358,000 | -11.9% | 2,709,825 | +0.9% | 0.00% | 0.0% |
Q4 2020 | $37,857,000 | +40.8% | 2,684,910 | +19.8% | 0.00% | 0.0% |
Q3 2020 | $26,885,000 | -26.0% | 2,240,550 | +2.4% | 0.00% | 0.0% |
Q2 2020 | $36,310,000 | +425.6% | 2,187,273 | +260.3% | 0.00% | – |
Q1 2020 | $6,908,000 | -7.5% | 607,032 | +0.1% | 0.00% | – |
Q4 2019 | $7,472,000 | +746.2% | 606,462 | +95.7% | 0.00% | – |
Q3 2019 | $883,000 | – | 309,840 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,386,300 | $19,547,000 | 2.55% |
EcoR1 Capital, LLC | 3,122,704 | $44,030,000 | 2.37% |
Redmile Group, LLC | 4,131,869 | $58,259,000 | 0.70% |
Boxer Capital, LLC | 1,501,058 | $21,165,000 | 0.68% |
HighVista Strategies LLC | 69,727 | $983,000 | 0.63% |
Baker Brothers Advisors | 3,821,740 | $53,887,000 | 0.20% |
Highland Private Wealth Management | 93,998 | $1,326,000 | 0.12% |
Sio Capital Management, LLC | 38,312 | $540,000 | 0.11% |
Point72 Asset Management, L.P. | 1,195,725 | $16,860,000 | 0.08% |
Granahan Investment Management | 246,299 | $3,473,000 | 0.08% |